Beyond mRNA: FDA’s Marks Calls For Platform Agnostic Search For Better COVID Vaccines

Marks opines on what sponsors would need to do to bring a ‘better’ vaccine to market in a NEJM interview. Meanwhile, CDC releases real world data on estimated bivalent booster efficacy.

Bride running away from groom
FDA’s Peter Marks says it would be a mistake to be ‘wedded’ to early COVID vaccine technology • Source: Shutterstock

A systematic, platform-agnostic search is needed to get new and improved COVID-19 vaccines that provide longer and broader immunity, US Food and Drug Administration’s Peter Marks urged in recent New England Journal of Medicine interview.

More work needs to be done to “keep ahead of the virus,” the Center for Biologics Evaluation and Research Director...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Vaccines

More from Pink Sheet